Abercrombie & Fitch opened higher at $152.19, compared with its previous close of $151.92. In the last trading session, the stock traded between $148.56 and $153.52. It showed a downward intraday trend.
Return calculator
Time Period
An investment of $100 made 5 years ago in Abercrombie & Fitch is now worth
$ 332.15
Giving a profit of
$ 232.15 (232.15%)
Invest with $1
Note: Past profits do not guarantee future returns.
UBS raises Abercrombie & Fitch price target to $200. Rating maintained at Buy by analyst Mauricio Serna. Previous price target was set at $185.
Yesterday
28Aug
Abercrombie & Fitch Q2 EPS beats at $4.17; raises full-year outlook
Revenue hits record $1.27B; adjusted EPS of $4.17 beats consensus of ~$1.99. Tariff refund of ~$100M contributes 790 bps to operating margin of 19.9%. 15th consecutive quarter of top-line growth; APAC sales up 19%. Full-year FY26 EPS guidance raised to $13.10-$13.60; sales growth target set at 5%. Shares surge 40% post-earnings, consolidating near 52-week high on Thursday.
2mo ago
27Aug
Barclays raises Abercrombie & Fitch price target to $155
Barclays raises Abercrombie & Fitch price target to $155. Previous target was $114, representing a significant increase. Rating remains Equal-Weight per analyst Adrienne Yih.
2mo ago
26Aug
Abercrombie shares jump 31.6% on Q2 beat, raised outlook
Shares surged 31.6% to $143.40 on Q2 FY26 beat and raised guidance. Net sales rose 5% YoY to $1.267 billion; adjusted EPS hit $2.42 vs $1.99 est. CFO cites stronger assortments and lower discounts for improved AUR. Full-year EPS guidance raised to $13.10-$13.60 from $10.20-$11.00.
Abercrombie & Fitch guides Q3 GAAP EPS at $2.90-$3.20 vs $2.84 estimate. Sales projected at $1.355B-$1.367B against $1.345B analyst estimate. Lower EPS bound exceeds consensus, indicating potential upside.
2mo ago
26Aug
Abercrombie & Fitch raises FY26 EPS guidance to $13.10-$13.60
Raises FY2026 GAAP EPS guidance to $13.10-$13.60 from $10.20-$11.00. New EPS range beats analyst estimate of $10.71 by a wide margin. Increases FY2026 sales guidance to $5.529 billion from $5.424B-$5.529B. Revised sales target exceeds analyst estimate of $5.464 billion.
